A recently discovered strain of gonorrhea is now causing health officials to panic in the UK because of how resistant it is to medical treatment and how severely contagious it appears. This is just the latest development in the escalating threat of superbugs that are the result of misusing over-the-counter medicine. This time, however, it seems the threat is on a public health level.
Superbugs might be old news, but this new super-powered strain of gonorrhea is no laughing matter. As The Guardian notes, this is the first time that the infection has managed to resist all standard antibiotics. The patient to suffer the disease has apparently had several sexual encounters both in the UK and in Southeast Asia, so the country’s health department is now trying to contain the situation.
Cases wherein diseases start to affect public health in developed countries are actually quite rare, all things considered, and there’s a reason for it. Governments in industrialized nations have learned their lesson after the Spanish flu absolutely decimated entire communities all over the world.
In the case of this super gonorrhea, it seems it’s just the one case reported, but with such a virulent bug, it’s always better to be safe than risk an outbreak. The patient’s partner has also been tested for the bug and has appeared to be free of the infection.
The biggest problem when it comes to superbugs is the fact that developing new antibiotics is difficult, Futurism reports. The drug actually hasn’t moved that far following the discovery of penicillin and a huge part of this is because drug companies are not providing enough funding into antibiotic R&D.
There’s hardly any money to be made in developing antibiotics that can take on super bacteria, at this point, which is why there’s hardly any investment. If the evolution of superbugs continues on its current trajectory, however, this could soon change.


Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco
Elon Musk Announces Terafab: SpaceX and Tesla to Build Dual AI Chip Factories in Austin, Texas
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion
Reflection AI Eyes $25 Billion Valuation in Massive $2.5 Billion Funding Round
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield
Elliott Investment Management Takes Multibillion-Dollar Stake in Synopsys
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo
Amazon's "Transformer" Phone: Can It Succeed Where Fire Phone Failed?
Rubio Directs U.S. Diplomats to Use X and Military Psyops to Counter Foreign Propaganda
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion
Makemation: a Nollywood movie that shows AI in action in Africa
California's AI Executive Order Pushes Responsible Tech Use in State Contracts
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership 



